Obsessive-Compulsive Disorder Medicine Market, Global Outlook and Forecast 2023-2029

Report ID: MMG34081 | Category: Pharma & Healthcare | Pages: 119 | Format: PDF | Published Date: February 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
This report aims to provide a comprehensive presentation of the global market for Obsessive-Compulsive Disorder Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obsessive-Compulsive Disorder Medicine. This report contains market size and forecasts of Obsessive-Compulsive Disorder Medicine in global, including the following market information:
Global Obsessive-Compulsive Disorder Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Obsessive-Compulsive Disorder Medicine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Obsessive-Compulsive Disorder Medicine companies in 2022 (%)
The global Obsessive-Compulsive Disorder Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
NMDA Receptor Blockers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Obsessive-Compulsive Disorder Medicine include Sun pharmaceuticals industry Ltd., H.Lunderbeck A/S, Eli Lilly and company, Apotex Inc., Viatris Inc., Lannett, GlaxoSmithKline Plc., Alvogen and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obsessive-Compulsive Disorder Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obsessive-Compulsive Disorder Medicine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Obsessive-Compulsive Disorder Medicine Market Segment Percentages, by Type, 2022 (%)
    NMDA Receptor Blockers
    Antipsychotics
    Antidepressants
Global Obsessive-Compulsive Disorder Medicine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Obsessive-Compulsive Disorder Medicine Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Homecare
    Clinics
    Others
Global Obsessive-Compulsive Disorder Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Obsessive-Compulsive Disorder Medicine Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Obsessive-Compulsive Disorder Medicine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Obsessive-Compulsive Disorder Medicine revenues share in global market, 2022 (%)
Key companies Obsessive-Compulsive Disorder Medicine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Obsessive-Compulsive Disorder Medicine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sun pharmaceuticals industry Ltd.
    H.Lunderbeck A/S
    Eli Lilly and company
    Apotex Inc.
    Viatris Inc.
    Lannett
    GlaxoSmithKline Plc.
    Alvogen
    Pfizer Inc.
    Amneal Pharmaceuticals LLC.
    Dr. Reddy's Laboratories Ltd.
    Abbott
    Par Pharmaceuticals
    Sebela Pharmaceuticals
    Mallinckrodt
    Lupin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Obsessive-Compulsive Disorder Medicine, market overview.
Chapter 2: Global Obsessive-Compulsive Disorder Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Obsessive-Compulsive Disorder Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Obsessive-Compulsive Disorder Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Obsessive-Compulsive Disorder Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Obsessive-Compulsive Disorder Medicine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Obsessive-Compulsive Disorder Medicine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Obsessive-Compulsive Disorder Medicine Overall Market Size
    2.1 Global Obsessive-Compulsive Disorder Medicine Market Size: 2022 VS 2029
    2.2 Global Obsessive-Compulsive Disorder Medicine Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Obsessive-Compulsive Disorder Medicine Sales: 2018-2029
3 Company Landscape
    3.1 Top Obsessive-Compulsive Disorder Medicine Players in Global Market
    3.2 Top Global Obsessive-Compulsive Disorder Medicine Companies Ranked by Revenue
    3.3 Global Obsessive-Compulsive Disorder Medicine Revenue by Companies
    3.4 Global Obsessive-Compulsive Disorder Medicine Sales by Companies
    3.5 Global Obsessive-Compulsive Disorder Medicine Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Obsessive-Compulsive Disorder Medicine Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Obsessive-Compulsive Disorder Medicine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Obsessive-Compulsive Disorder Medicine Players in Global Market
        3.8.1 List of Global Tier 1 Obsessive-Compulsive Disorder Medicine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Obsessive-Compulsive Disorder Medicine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Obsessive-Compulsive Disorder Medicine Market Size Markets, 2022 & 2029
        4.1.2 NMDA Receptor Blockers
        4.1.3 Antipsychotics
        4.1.4 Antidepressants
    4.2 By Type - Global Obsessive-Compulsive Disorder Medicine Revenue & Forecasts
        4.2.1 By Type - Global Obsessive-Compulsive Disorder Medicine Revenue, 2018-2023
        4.2.2 By Type - Global Obsessive-Compulsive Disorder Medicine Revenue, 2024-2029
        4.2.3 By Type - Global Obsessive-Compulsive Disorder Medicine Revenue Market Share, 2018-2029
    4.3 By Type - Global Obsessive-Compulsive Disorder Medicine Sales & Forecasts
        4.3.1 By Type - Global Obsessive-Compulsive Disorder Medicine Sales, 2018-2023
        4.3.2 By Type - Global Obsessive-Compulsive Disorder Medicine Sales, 2024-2029
        4.3.3 By Type - Global Obsessive-Compulsive Disorder Medicine Sales Market Share, 2018-2029
    4.4 By Type - Global Obsessive-Compulsive Disorder Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Obsessive-Compulsive Disorder Medicine Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Homecare
        5.1.4 Clinics
        5.1.5 Others
    5.2 By Application - Global Obsessive-Compulsive Disorder Medicine Revenue & Forecasts
        5.2.1 By Application - Global Obsessive-Compulsive Disorder Medicine Revenue, 2018-2023
        5.2.2 By Application - Global Obsessive-Compulsive Disorder Medicine Revenue, 2024-2029
        5.2.3 By Application - Global Obsessive-Compulsive Disorder Medicine Revenue Market Share, 2018-2029
    5.3 By Application - Global Obsessive-Compulsive Disorder Medicine Sales & Forecasts
        5.3.1 By Application - Global Obsessive-Compulsive Disorder Medicine Sales, 2018-2023
        5.3.2 By Application - Global Obsessive-Compulsive Disorder Medicine Sales, 2024-2029
        5.3.3 By Application - Global Obsessive-Compulsive Disorder Medicine Sales Market Share, 2018-2029
    5.4 By Application - Global Obsessive-Compulsive Disorder Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Obsessive-Compulsive Disorder Medicine Market Size, 2022 & 2029
    6.2 By Region - Global Obsessive-Compulsive Disorder Medicine Revenue & Forecasts
        6.2.1 By Region - Global Obsessive-Compulsive Disorder Medicine Revenue, 2018-2023
        6.2.2 By Region - Global Obsessive-Compulsive Disorder Medicine Revenue, 2024-2029
        6.2.3 By Region - Global Obsessive-Compulsive Disorder Medicine Revenue Market Share, 2018-2029
    6.3 By Region - Global Obsessive-Compulsive Disorder Medicine Sales & Forecasts
        6.3.1 By Region - Global Obsessive-Compulsive Disorder Medicine Sales, 2018-2023
        6.3.2 By Region - Global Obsessive-Compulsive Disorder Medicine Sales, 2024-2029
        6.3.3 By Region - Global Obsessive-Compulsive Disorder Medicine Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Obsessive-Compulsive Disorder Medicine Revenue, 2018-2029
        6.4.2 By Country - North America Obsessive-Compulsive Disorder Medicine Sales, 2018-2029
        6.4.3 US Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.4.4 Canada Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.4.5 Mexico Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Obsessive-Compulsive Disorder Medicine Revenue, 2018-2029
        6.5.2 By Country - Europe Obsessive-Compulsive Disorder Medicine Sales, 2018-2029
        6.5.3 Germany Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.5.4 France Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.5.5 U.K. Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.5.6 Italy Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.5.7 Russia Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.5.8 Nordic Countries Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.5.9 Benelux Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Obsessive-Compulsive Disorder Medicine Revenue, 2018-2029
        6.6.2 By Region - Asia Obsessive-Compulsive Disorder Medicine Sales, 2018-2029
        6.6.3 China Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.6.4 Japan Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.6.5 South Korea Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.6.6 Southeast Asia Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.6.7 India Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Obsessive-Compulsive Disorder Medicine Revenue, 2018-2029
        6.7.2 By Country - South America Obsessive-Compulsive Disorder Medicine Sales, 2018-2029
        6.7.3 Brazil Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.7.4 Argentina Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Obsessive-Compulsive Disorder Medicine Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Obsessive-Compulsive Disorder Medicine Sales, 2018-2029
        6.8.3 Turkey Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.8.4 Israel Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.8.5 Saudi Arabia Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
        6.8.6 UAE Obsessive-Compulsive Disorder Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Sun pharmaceuticals industry Ltd.
        7.1.1 Sun pharmaceuticals industry Ltd. Company Summary
        7.1.2 Sun pharmaceuticals industry Ltd. Business Overview
        7.1.3 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.1.4 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.1.5 Sun pharmaceuticals industry Ltd. Key News & Latest Developments
    7.2 H.Lunderbeck A/S
        7.2.1 H.Lunderbeck A/S Company Summary
        7.2.2 H.Lunderbeck A/S Business Overview
        7.2.3 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.2.4 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.2.5 H.Lunderbeck A/S Key News & Latest Developments
    7.3 Eli Lilly and company
        7.3.1 Eli Lilly and company Company Summary
        7.3.2 Eli Lilly and company Business Overview
        7.3.3 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.3.4 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.3.5 Eli Lilly and company Key News & Latest Developments
    7.4 Apotex Inc.
        7.4.1 Apotex Inc. Company Summary
        7.4.2 Apotex Inc. Business Overview
        7.4.3 Apotex Inc. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.4.4 Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.4.5 Apotex Inc. Key News & Latest Developments
    7.5 Viatris Inc.
        7.5.1 Viatris Inc. Company Summary
        7.5.2 Viatris Inc. Business Overview
        7.5.3 Viatris Inc. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.5.4 Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.5.5 Viatris Inc. Key News & Latest Developments
    7.6 Lannett
        7.6.1 Lannett Company Summary
        7.6.2 Lannett Business Overview
        7.6.3 Lannett Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.6.4 Lannett Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.6.5 Lannett Key News & Latest Developments
    7.7 GlaxoSmithKline Plc.
        7.7.1 GlaxoSmithKline Plc. Company Summary
        7.7.2 GlaxoSmithKline Plc. Business Overview
        7.7.3 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.7.4 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.7.5 GlaxoSmithKline Plc. Key News & Latest Developments
    7.8 Alvogen
        7.8.1 Alvogen Company Summary
        7.8.2 Alvogen Business Overview
        7.8.3 Alvogen Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.8.4 Alvogen Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.8.5 Alvogen Key News & Latest Developments
    7.9 Pfizer Inc.
        7.9.1 Pfizer Inc. Company Summary
        7.9.2 Pfizer Inc. Business Overview
        7.9.3 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.9.4 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.9.5 Pfizer Inc. Key News & Latest Developments
    7.10 Amneal Pharmaceuticals LLC.
        7.10.1 Amneal Pharmaceuticals LLC. Company Summary
        7.10.2 Amneal Pharmaceuticals LLC. Business Overview
        7.10.3 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.10.4 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.10.5 Amneal Pharmaceuticals LLC. Key News & Latest Developments
    7.11 Dr. Reddy's Laboratories Ltd.
        7.11.1 Dr. Reddy's Laboratories Ltd. Company Summary
        7.11.2 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Business Overview
        7.11.3 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.11.4 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.11.5 Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
    7.12 Abbott
        7.12.1 Abbott Company Summary
        7.12.2 Abbott Obsessive-Compulsive Disorder Medicine Business Overview
        7.12.3 Abbott Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.12.4 Abbott Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.12.5 Abbott Key News & Latest Developments
    7.13 Par Pharmaceuticals
        7.13.1 Par Pharmaceuticals Company Summary
        7.13.2 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Business Overview
        7.13.3 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.13.4 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.13.5 Par Pharmaceuticals Key News & Latest Developments
    7.14 Sebela Pharmaceuticals
        7.14.1 Sebela Pharmaceuticals Company Summary
        7.14.2 Sebela Pharmaceuticals Business Overview
        7.14.3 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.14.4 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.14.5 Sebela Pharmaceuticals Key News & Latest Developments
    7.15 Mallinckrodt
        7.15.1 Mallinckrodt Company Summary
        7.15.2 Mallinckrodt Business Overview
        7.15.3 Mallinckrodt Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.15.4 Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.15.5 Mallinckrodt Key News & Latest Developments
    7.16 Lupin
        7.16.1 Lupin Company Summary
        7.16.2 Lupin Business Overview
        7.16.3 Lupin Obsessive-Compulsive Disorder Medicine Major Product Offerings
        7.16.4 Lupin Obsessive-Compulsive Disorder Medicine Sales and Revenue in Global (2018-2023)
        7.16.5 Lupin Key News & Latest Developments
8 Global Obsessive-Compulsive Disorder Medicine Production Capacity, Analysis
    8.1 Global Obsessive-Compulsive Disorder Medicine Production Capacity, 2018-2029
    8.2 Obsessive-Compulsive Disorder Medicine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Obsessive-Compulsive Disorder Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Obsessive-Compulsive Disorder Medicine Supply Chain Analysis
    10.1 Obsessive-Compulsive Disorder Medicine Industry Value Chain
    10.2 Obsessive-Compulsive Disorder Medicine Upstream Market
    10.3 Obsessive-Compulsive Disorder Medicine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Obsessive-Compulsive Disorder Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Obsessive-Compulsive Disorder Medicine Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?